መነሻ › ኖን-ስማል ሴል የሳንባ ካንሰር › አዮዋ › Des Moines
በDes Moines፣ IA ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ 11 ጥናቶች በDes Moines እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- እና 5 ተጨማሪ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- እና 5 ተጨማሪ
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Iowa Health Care, Mission Cancer + Blood, Waukee · 14 ማይል ርቀት
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Des Moines
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Clinical Study Site, Waukee · 14 ማይል ርቀት
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mission Cancer + Blood - IMMC, Des Moines
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Mercy Medical Center - Des Moines, Des Moines
- እና 4 ተጨማሪ
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Mercy Medical Center - Des Moines, Des Moines
- እና 4 ተጨማሪ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines
- እና 3 ተጨማሪ
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mission Cancer + Blood - Mission Cancer Foundation, Des Moines
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- እና 6 ተጨማሪ
በሌሎች ከተሞች ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ጥናቶች
- Houston, TX145 ጥናቶች
- New York City, NY121 ጥናቶች
- Arlington, VA104 ጥናቶች
- Nashville, TN97 ጥናቶች
- Boston, MA90 ጥናቶች
- Los Angeles, CA87 ጥናቶች
- St. Louis, MO73 ጥናቶች
- Chicago, IL61 ጥናቶች
- Baltimore, MD60 ጥናቶች
- San Antonio, TX59 ጥናቶች
- Columbus, OH57 ጥናቶች
- Washington, DC55 ጥናቶች
በDes Moines ውስጥ ያሉ ሌሎች ጥናቶች
- የሳንባ ካንሰር10 ጥናቶች
- የጡንቻ ካንሰር8 ጥናቶች
- የኮሎሬክታል ካንሰር8 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ8 ጥናቶች
- የሽንት ፊኛ ካንሰር6 ጥናቶች
- ከመጠን በላይ ክብደት6 ጥናቶች
- Multiple Myeloma5 ጥናቶች
- ከባድ ሰውነት5 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ5 ጥናቶች
- የ2 ዓይነት ስኳረት5 ጥናቶች
- የልብና የደም ዝውውር ሕመም5 ጥናቶች
- ዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ5 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።